02.11.2022 • News

India’s Dorf Ketal Takes Clariant’s North American Land Oil Business

Indian specialty chemical company Dorf Ketal has agreed to acquire Clariant’s North American land oil business for an undisclosed sum.

© Zora Zhuang /Getty Images
© Zora Zhuang /Getty Images

Dorf Ketal said the business, which generated revenues of $113 million in 2021, represents an “exciting growth opportunity”. The purchase includes manufacturing facilities in Bakersfield, California and in Midland and Black Hills, both in Texas, producing more than 2,000 formulations for drilling, production and stimulation, as well as 170 employees and a technology portfolio of more than 40 patent families.

“This acquisition will bring additional strategic assets, innovative new technology, talented people, and strong customer relationships into Dorf Ketal,” said Sudhir Menon, chairman of Dorf Ketal Chemicals India. “Upon completion, it will enable our continued growth in North America – a significant and growing market for energy services, further aligning with our global focus and commitment to providing innovative services throughout the energy sector.”

The transaction is expected to close during the first quarter of 2023, subject to regulatory approvals and customary conditions.

Clariant said the divestment is another “logical step” in repositioning its portfolio toward true specialty chemicals and its sustainability transformation. In August, the Swiss group agreed the sale of its Quats business to Global Amines, a joint venture owned in equal share by Clariant and Singapore’s Wilmar.

Author: Elaine Burridge, Freelance Journalist

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.